创伤患者氨甲环酸使用评估:一项回顾性定量分析
该回顾性病历审查利用不列颠哥伦比亚创伤登记处,连续纳入2012年4月至2015年6月期间就诊于皇家哥伦比亚医院(Royal Columbian Hospital)急诊科、符合氨甲环酸指征(收缩压<90 mm Hg和/或心率>110 bpm,且伤后8 h内就诊)的创伤患者。共117例(2.7%)符合指征,其中67例(57%)接受任意剂量氨甲环酸,仅10例(8.5%)按CRASH-2方案给药;接受氨甲环酸者中76%在伤后≤3 h给药,22例(19%)接受了院前剂量。作者认为需进一步调查创伤患者未接受氨甲环酸的原因并开展创伤救治质量改进措施。
要点
- 符合氨甲环酸指征(收缩压<90 mm Hg和/或心率>110 bpm,伤后8 h内就诊)的成人创伤患者中,仅57%(67/117)接受了任意剂量氨甲环酸。
- 接受氨甲环酸的患者中仅8.5%(10/117)按CRASH-2方案给药,<10%的符合指征者接受了规范方案治疗。
- 接受任意剂量氨甲环酸的67例中,76%在伤后≤3 h内给药,22例(19%)接受了院前剂量。
- 作者认为需进一步调查创伤患者未接受氨甲环酸的原因,并开展创伤救治质量改进措施。
适用人群与场景
- 2012年4月至2015年6月期间就诊于皇家哥伦比亚医院(Royal Columbian Hospital)急诊科的成人创伤患者,符合氨甲环酸指征:收缩压<90 mm Hg和/或心率>110 bpm,且伤后8 h内就诊。
诊断标准与关键阈值
- 氨甲环酸指征:收缩压<90 mm Hg和/或心率>110 bpm,且伤后8 h内就诊。
研究设计与关键结果
- 研究类型:回顾性病历审查,利用不列颠哥伦比亚创伤登记处连续纳入100例符合指征的创伤患者(原文另述117例受试者(2.7%)符合氨甲环酸指征)。
- 主要结局:117例(2.7%)符合氨甲环酸指征;67例(57%)接受任意剂量氨甲环酸;10例(8.5%)按CRASH-2方案给药。
- 接受任意剂量氨甲环酸的67例中,76%在伤后≤3 h内给药;22例(19%)接受了院前剂量。
证据类型、等级与局限
- 证据类型:回顾性病历审查(治疗性研究),证据等级III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为需进一步调查创伤患者未接受氨甲环酸的原因,并开展创伤救治质量改进措施。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Tranexamic acid (TXA) has been shown to decrease mortality in adult trauma patients with or at significant risk of hemorrhage when administered within 3 h of injury. The use and appropriateness of TXA in adult trauma patients presenting to Royal Columbian Hospital (RCH) was investigated.
METHODS: This retrospective chart review utilized the British Columbia Trauma Registry to identify 100 consecutive trauma patients that presented to the emergency department at RCH between April 2012 to June 2015 and met the following indications for TXA: systolic blood pressure <90 mm Hg and/or heart rate >110 bpm and presentation within 8 h of injury. Primary outcomes included: percentage that met indications for TXA, received TXA according to the CRASH-2 protocol, received a pre-hospital dose, and received TXA ≤1, >1 to ≤3, or >3 h from injury.
RESULTS: During the given time period, 117 subjects (2.7%) met indications for TXA. 67 patients (57%) received TXA in any dose, with 10 subjects (8.5%) receiving TXA according to the CRASH-2 protocol. Of the 67 patients who received any TXA, 76% did so ≤3 h. 22 patients (19%) received TXA as a pre-hospital dose.
CONCLUSIONS: <10% of adult trauma patients that met the indication for TXA received it according to the CRASH-2 protocol. Of those patients that received TXA, 76% did so within 3 h. Further inquiry to identify reasons trauma patients are not receiving TXA as well as quality improvement initiatives in trauma care are required.
LEVEL OF EVIDENCE: III STUDY TYPE: Therapeutic.
参考来源
- Ng M, Perrott J, Burgess S, et al. Evaluation of tranexamic acid in trauma patients: A retrospective quantitative analysis. Am J Emerg Med. 2018. PMID: 29903672. doi:10.1016/j.ajem.2018.06.010
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。